Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose Escalation Study of Stereotactic Body Radiotherapy for Carcinoma of the Head and Neck in High Risk Patients Who Are Ineligible/Refuse Standard of Care Therapy

NCT02388932 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT02388932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose Escalation Study of Stereotactic Body Radiotherapy for Carcinoma of the Head and Neck in High Risk Patients Who Are Ineligible/Refuse Standard of Care Therapy
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
March 3, 2015
Completion date
February 6, 2017
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent hypopharyngeal squamous cell carcinoma, recurrent laryngeal squamous cell carcinoma, recurrent nasal cavity and paranasal sinus squamous cell carcinoma, recurrent nasopharyngeal keratinizing squamous cell carcinoma, recurrent oral cavity squamous cell carcinoma, recurrent oropharyngeal squamous cell carcinoma, stage ii nasopharyngeal keratinizing squamous cell carcinoma, stage iii hypopharyngeal squamous cell carcinoma, stage iii laryngeal squamous cell carcinoma, stage iii nasal cavity and paranasal sinus squamous cell carcinoma, stage iii nasopharyngeal keratinizing squamous cell carcinoma, stage iii oral cavity squamous cell carcinoma, stage iii oropharyngeal squamous cell carcinoma, stage iva hypopharyngeal squamous cell carcinoma, stage iva laryngeal squamous cell carcinoma, stage iva nasopharyngeal keratinizing squamous cell carcinoma, stage iva oral cavity squamous cell carcinoma, stage iva oropharyngeal squamous cell carcinoma, stage ivb hypopharyngeal squamous cell carcinoma, stage ivb laryngeal squamous cell carcinoma, stage ivb nasopharyngeal keratinizing squamous cell carcinoma, stage ivb oral cavity squamous cell carcinoma, stage ivb oropharyngeal squamous cell carcinoma, stage ivc hypopharyngeal squamous cell carcinoma, stage ivc laryngeal squamous cell carcinoma, stage ivc nasopharyngeal keratinizing squamous cell carcinoma, stage ivc oral cavity squamous cell carcinoma, stage ivc oropharyngeal squamous cell carcinoma